Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

908 Devices (MASS) EBT (2020 - 2026)

908 Devices has reported EBT over the past 6 years, most recently at $4.2 million for Q4 2025.

  • Quarterly EBT rose 126.29% to $4.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$33.7 million through Dec 2025, up 42.1% year-over-year, with the annual reading at -$33.3 million for FY2025, 37.25% up from the prior year.
  • EBT was $4.2 million for Q4 2025 at 908 Devices, up from -$14.9 million in the prior quarter.
  • Over five years, EBT peaked at $4.2 million in Q4 2025 and troughed at -$23.6 million in Q3 2024.
  • The 5-year median for EBT is -$8.7 million (2022), against an average of -$9.2 million.
  • Year-over-year, EBT plummeted 498.19% in 2021 and then surged 126.29% in 2025.
  • A 5-year view of EBT shows it stood at -$3.6 million in 2021, then plummeted by 174.41% to -$9.8 million in 2022, then grew by 24.1% to -$7.4 million in 2023, then tumbled by 115.64% to -$16.0 million in 2024, then surged by 126.29% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for MASS's EBT are $4.2 million (Q4 2025), -$14.9 million (Q3 2025), and -$12.8 million (Q2 2025).